在患有偏头痛的患者中,快速查通用焦虑症
Fatemeh Veisy1,2,3, Hojjatollah Farahani4, Mansoureh Togha5
1Department of Clinical Psychology, School of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, Iran.
Current journal of neurology
|November 27, 2023
概括
在偏头痛患者中,使用波斯版本的通用焦虑障碍量表7项 (GAD-7) 和GAD-2的通用焦虑障碍 (GAD) 查是有效的. 这些经过验证的工具准确地识别了GAD,改善了这一群体的诊断和管理.
科学领域:
- 精神病学和神经病学的精神病学和神经病学
- 临床心理学 临床心理学
- 精神疾病的流行病学 精神疾病的流行病学
背景情况:
- 一般焦虑症 (GAD) 与偏头痛的并发症很普遍,并且与患者功能障碍和慢性偏头痛风险的增加有关.
- 偏头痛患者未被诊断的GAD可能会加剧症状,并对生活质量产生负面影响.
- 综合焦虑障碍尺度7项 (GAD-7) 和GAD-2被广泛用于查综合焦虑症状.
研究的目的:
- 在被诊断为偏头痛的患者中评估GAD-7和GAD-2查工具的波斯版本的心理测量特性和诊断准确性.
- 确定GAD-7和GAD-2的可靠性和有效性,用于在偏头痛患者队列中识别GAD.
主要方法:
- 一项涉及186名偏头痛患者的横截面研究,根据国际头痛疾病分类第3版 (ICHD-3) 诊断.
- 参与者接受了精神科采访,并完成了验证的问卷,包括GAD-7,GAD-2,贝克焦虑清单 (BAI),头痛影响测试-6 (HIT-6) 和偏头痛特异性生活质量问卷 (MSQv2.1).
- 使用SPSS和LISREL分析了心理测量属性,包括确认因素分析 (CFA),可靠性 (内部一致性,测试重试,Guttman分半) 和构造有效性 (AVE,CR).
主要成果:
- 在186名偏头痛患者中,83人被诊断出患有GAD. 确认因素分析支持波斯GAD-7的一个因素模型.
- GAD-7和GAD-2都表现出良好的内部一致性,测试-重新测试可靠性和Guttman分半可靠性.
- 波斯GAD-7显示出强大的构造有效性. 最佳切线分数 (GAD-7 ≥10,GAD-2 ≥3) 产生了高灵敏度,特异性,PPV和NPV,表明了出色的诊断准确性.
结论:
- 波斯语版本的GAD-7和GAD-2是可靠和有效的工具,用于评估患有偏头痛的患者的泛性焦虑障碍.
- 这些查工具可以准确地识别偏头痛患者中的GAD,促进及时诊断和适当的管理策略.
- 实施GAD-7和GAD-2查可以通过解决伴随性焦虑来改善偏头痛患者的综合护理.
相关概念视频
01:30Generalized Anxiety Disorder
135
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
135
01:18Anxiety: Overview
280
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
280
01:26Anxiolytic Drugs: Overview
325
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
325
01:27Panic Disorder
114
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
114
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
798
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
798